---
title: "Genomic alterations in histologically clear dysplasia margins predict advanced neoplasia in ulcera"
id: "medrxiv-7-genomic-alterations-in-histologically-clear-low-grade-dysplasia-resection"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-7-genomic-alterations-in-histologically-clear-low-grade-dysplasia-resection"
content_type: "clinical_feed_article"
specialty: "Gastroenterology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.10.26362759v1?rss=1"
published_at: "2026-09-11T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Genomic alterations in histologically clear dysplasia margins predict advanced neoplasia in ulcera
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-7-genomic-alterations-in-histologically-clear-low-grade-dysplasia-resection
- **Specialty:** [Gastroenterology](https://medichelpline.com/clinical-feed/gastroenterology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.10.26362759v1?rss=1)
- **Published At:** 2026-09-11T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Endoscopic resection of dysplasia in ulcerative colitis (UC) can be followed by development of **advanced neoplasia** (AN) despite histologically clear margins, suggesting occult risk in surrounding mucosa. - The study retrospectively analysed 51 UC patients who underwent endoscopic resection of dysplastic lesions with a median follow-up of 1947 days; 11 patients experienced local progression to AN. - Low-coverage whole-genome sequencing (lcWGS) was performed on 56 dysplastic lesions and 91 adjacent histologically non-dysplastic resection margins to assess somatic copy number alteration burden and phylogenetic relationships. - Histologically non-dysplastic margins from lesions that later progressed to AN had a significantly higher **copy number alteration (CNA) burden** than margins from non-progressing lesions. - In multivariate analysis, high margin CNA burden was independently associated with local progression, whereas traditional features such as histologically clear resection margins and en bloc excisions were not independently predictive. - The findings indicate that histological clearance does not necessarily equate to elimination of the cancerised field; genomic detection of **field cancerisation** in non-dysplastic margins can identify patients at increased risk. - The authors propose margin genomic profiling as a potential biomarker to inform post-resection surveillance strategies in UC-associated dysplasia. - The study was conducted at a tertiary referral centre, ethics approval was obtained from the London — south east research and ethics committee, and data are available on reasonable request. The authors declared no competing interests.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=Pa7_mqq78q64P1M1ujhNnCBZ0Uw.vbUjkpZCB9Mh2Vo-1789252951.3041549-1.2.1.1-pQ1slYrHJe7ljlSxChrlB8_qcKtqf5EsO8pCojzgqEdtxaiW2KMYpFATbYK4uK5g) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.10.26362759v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Genomic alterations in histologically clear low grade dysplasia resection margins forecast advanced neoplasia in ulcerative colitis Jennifer Fisher, Konstantin Brautigam, Heather E Grant, Maximillian Mossner, Chirine Sakr, Ibrahim Al Bakir, Brian Saunders, Noriko Suzuki, Ana Wilson, Ann-Marie Baker, Ailsa L Hart, Trevor A Graham doi: https://doi.org/10.64898/2026.09.10.26362759 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Jennifer Fisher 1 Institute of Cancer Research; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jennifer%2BFisher%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fisher%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJennifer%2BFisher%2B) Konstantin Brautigam 2 Institute of Cancer; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Konstantin%2BBrautigam%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Brautigam%20K&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKonstantin%2BBrautigam%2B) Heather E Grant 1 Institute of Cancer Research; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Heather%2BE%2BGrant%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Grant%20HE&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHeather%2BE%2BGrant%2B) Maximillian Mossner 1 Institute of Cancer Research; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Maximillian%2BMossner%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mossner%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMaximillian%2BMossner%2B) Chirine Sakr 1 Institute of Cancer Research; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Chirine%2BSakr%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sakr%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChirine%2BSakr%2B) Ibrahim Al Bakir 3 Chelsea and Westminster Hospital; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ibrahim%2BAl%2BBakir%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Al%20Bakir%20I&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AIbrahim%2BAl%2BBakir%2B) Brian Saunders 4 St Marks Hospital and Academic Institute * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Brian%2BSaunders%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Saunders%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABrian%2BSaunders%2B) Noriko Suzuki 4 St Marks Hospital and Academic Institute * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Noriko%2BSuzuki%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Suzuki%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANoriko%2BSuzuki%2B) Ana Wilson 4 St Marks Hospital and Academic Institute * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ana%2BWilson%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Wilson%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAna%2BWilson%2B) Ann-Marie Baker 1 Institute of Cancer Research; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ann-Marie%2BBaker%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Baker%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAnn-Marie%2BBaker%2B) Ailsa L Hart 4 St Marks Hospital and Academic Institute * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ailsa%2BL%2BHart%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hart%20AL&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAilsa%2BL%2BHart%2B) Trevor A Graham 1 Institute of Cancer Research; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Trevor%2BA%2BGraham%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Graham%20TA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATrevor%2BA%2BGraham%2B) * For correspondence: trevor.graham@icr.ac.uk * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.10.26362759v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1298593/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.10.26362759v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1298593/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.10.26362759v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1298593/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.10.26362759v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1298593/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.10.26362759v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1298593/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background Endoscopic resection is used for the management of dysplasia in ulcerative colitis (UC), but a subset of patients develop subsequent advanced neoplasia (AN), i.e., high-grade dysplasia and/or colorectal cancer, despite apparently complete resection with histologically clear margins. Current risk stratification relies predominantly on histopathological and procedural features, which does not capture underlying genomic field cancerization of morphologically normal mucosa. Objective To determine whether genomic alterations within histologically non-dysplastic resection margins are associated with subsequent neoplastic progression following endoscopic resection of UC-associated dysplasia. Design We analysed a retrospective cohort of 51 UC patients, who underwent endoscopic resection of dysplastic lesions at a tertiary referral centre, with a median follow-up of 1947 days. 11 of these had local progression. We performed low-coverage whole genome sequencing (lcWGS) of 56 dysplastic lesions and 91 adjacent histologically non-dysplastic margins. Somatic copy number alteration (CNA) burden and phylogenetic analysis were correlated with progression to AN . Results Histologically non-dysplastic margins from lesions that subsequently progressed to AN demonstrated significantly higher CNA burden compared with non-progressors. In multivariate analysis high margin CNA burden was independently associated with local progression, whereas histologically clear resection margins and en bloc excisions were not. Conclusion Histological clearance does not necessarily indicate clearance of the cancerised field in UC-associated dysplasia. Genomic detection of field cancerisation within histologically non-dysplastic resection margins identifies patients at increased risk of subsequent neoplasia and provides a potential biomarker for biologically informed post-resection surveillance. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: London - south east research and ethics committee gave ethical approval for this work I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors ## Funder Information Declared Bowel Cancer UK, https://ror.org/03ngjs524, 22PT00065 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC 4.0 International license](http://creativecommons.org/licenses/by-nc/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.10.26362759v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.09.26362677v1 "Amyloid-Independent Elevation of Plasma phosphorylated tau-217 Tracks Neurodegenerative Risk in Tuberous Sclerosis Complex: Implications for mTOR-Targeted Intervention")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.10.26362429v1 "Basket Trials in Gynaecology: A Simulation Study Comparing Novel Designs with Current Practice") Posted September 11, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.10.26362759v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/11/2026.09.10.26362759.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.10.26362759v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/11/2026.09.10.26362759.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Genomic alterations in histologically clear low grade dysplasia resection margins forecast advanced neoplasia in ulcerative colitis Jennifer Fisher, Konstantin Brautigam, Heather E Grant, Maximillian Mossner, Chirine Sakr, Ibrahim Al Bakir, Brian Saunders, Noriko Suzuki, Ana Wilson, Ann-Marie Baker, Ailsa L Hart, Trevor A Graham medRxiv 2026.09.10.26362759; doi: https://doi.org/10.64898/2026.09.10.26362759 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.10.26362759v1%26text%3DGenomic%2520alterations%2520in%2520histologically%2520clear%2520low%2520grade%2520dysplasia%2520resection%2520margins%2520forecast%2520advanced%2520neoplasia%2520in%2520ulcerative%2520colitis "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.10.26362759v1%26t%3DGenomic%2520alterations%2520in%2520histologically%2520clear%2520low%2520grade%2520dysplasia%2520resection%2520margins%2520forecast%2520advanced%2520neoplasia%2520in%2520ulcerative%2520colitis "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.10.26362759v1%26title%3DGenomic%2520alterations%2520in%2520histologically%2520clear%2520low%2520grade%2520dysplasia%2520resection%2520margins%2520forecast%2520advanced%2520neoplasia%2520in%2520ulcerative%2520colitis%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.10.26362759v1%26title%3DGenomic%2520alterations%2520in%2520histologically%2520clear%2520low%2520grade%2520dysplasia%2520resection%2520margins%2520forecast%2520advanced%2520neoplasia%2520in%2520ulcerative%2520colitis "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.10.26362759) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.10.26362759v1&count=horizontal&via=&text=Genomic%20alterations%20in%20histologically%20clear%20low%20grade%20dysplasia%20resection%20margins%20forecast%20advanced%20neoplasia%20in%20ulcerative%20colitis&counturl=www.medrxiv.org/content/10.64898/2026.09.10.26362759v1 "Tweet This") ## Subject Area * [Gastroenterology ](https://www.medrxiv.org/collection/gastroenterology) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (616) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (898) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (330) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4803) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (478) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (414) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (647) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1625) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15924) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1201) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7036) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (732) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1064) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5032) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1432) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1757) * [Hematology](https://www.medrxiv.org/collection/hematology) (584) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1343) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16281) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1170) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (667) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (153) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (722) * [Neurology](https://www.medrxiv.org/collection/neurology) (7259) * [Nursing](https://www.medrxiv.org/collection/nursing) (366) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1080) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1240)
## Related Clinical Research

- [IBDex frozen atlas converts bulk transcriptomics into reusable IBD reference](https://medichelpline.com/clinical-feed/medrxiv-17-ibdex-a-frozen-patient-scale-atlas-for-bulk-transcriptomics-in-inflammatory.md)
- [Follow-up Colonoscopy After Abnormal Stool-Based CRC Screening: Completion, Timeliness and Impleme](https://medichelpline.com/clinical-feed/bmj-open-21-follow-up-colonoscopy-after-abnormal-stool-based-colorectal-cancer-screening-a.md)
- [Inulin-driven gut microbiome changes increase sporadic colon cancer susceptibility in mice](https://medichelpline.com/clinical-feed/biorxiv-8-dietary-fiber-type-specific-gut-microbiome-preconditioning-drives-differential.md)
- [Author correction: SCREESCO trial cumulative incidence estimates for colorectal cancer screening a](https://medichelpline.com/clinical-feed/nature-3-author-correction-colonoscopy-and-fecal-immunochemical-testing-versus-usual.md)
- [CBC-derived inflammatory indices in colorectal cancer: diagnostic and prognostic head-to-head anal](https://medichelpline.com/clinical-feed/british-journal-of-cancer-0-complete-blood-count-derived-inflammation-indices-in-colorectal-cancer-head-to.md)

## Navigation
- [← Back to Gastroenterology Feed](https://medichelpline.com/clinical-feed/gastroenterology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.